SMAD4 and juvenile polyposis syndrome: In addition to these two genes, alteration of SMAD4 has been identified in a subset of patients with HHT and juvenile polyposis (approximately 2% of cases), a condition termed PJ-HHT syndrome, in which juvenile polyps and anemia are the predominant clinical features.